---
figid: PMC3196210__fnint-05-00064-g002
figtitle: Relationships of different neurons in the striatum and neurotransmitter
  signaling involved in interval timing
organisms:
- NA
pmcid: PMC3196210
filename: fnint-05-00064-g002.jpg
figlink: /pmc/articles/PMC3196210/figure/F2/
number: F2
caption: 'Relationships of different neurons in the striatum and neurotransmitter
  signaling involved in interval timing. (A) Schematic representation of the relationship
  among oscillatory cortical inputs, medium spiny neurons, cholinergic interneurons,
  glutamatergic afferents, and dopaminergic axons projecting from the substantia nigra
  pars compacta (SNpc) to the striatum as specified by the Striatal Beat Frequency
  model of interval timing. The direct output pathway to the globus pallidus – external
  (GPe) and internal (GPi) segments, and substantia nigra reticulata (SNr) as well
  as the indirect pathway to the GPe are indicated. Relevant neurotransmitters = acetylcholine
  (ACh), dopamine (DA), γ-aminobutyric acid (GABA), glutamate (GLU). (B) Detail of
  dopaminergic, glutamatergic, and cholinergic input to a striatonigral medium spiny
  neuron as well as the principal signal transduction pathways modulating the contribution
  of striatal spiny neurons to interval timing. Abbreviations: AC, adenyl cyclase;
  ACh, acetylcholine; AMPAR, AMPA receptor; CB1, cannabinoid receptor type 1; CRE,
  cyclic-AMP-response element; CREB, CRE binding protein; DA, dopamine; DAG, 1,2-diacylglycerol;
  DARPP-32, camp-regulated phosphoprotein of 32 kDa; D1R, dopamine D1 receptor; D2R,
  dopamine D2 receptor; EC, endocannabinoids; GABA, γ-aminobutyric acid; Glu, glutamate;
  GP, globus pallidus; IP3, inositol 1,4,5 trisphosphate; M1R, muscrinic acetylcholine
  receptor 1; M2R, muscarinic acetylcholine receptor 2; mGluR, metabotropic glutamate
  receptor; NMDAR, N-methyl-d-aspartic acid receptor; NOS, nitric oxide synthase;
  PKA, protein kinase A; PKC, protein kinase C; SNpc, substantia nigra pars compacta;
  SNr, substantia nigra pars reticulata; STN, subthalamic nucleus; TrKR, tyrosine
  kinase receptor.'
papertitle: Unwinding the Molecular Basis of Interval and Circadian Timing.
reftext: Patricia V. Agostino, et al. Front Integr Neurosci. 2011;5:64.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9146568
figid_alias: PMC3196210__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3196210__F2
ndex: bdac0f1c-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3196210__fnint-05-00064-g002.html
  '@type': Dataset
  description: 'Relationships of different neurons in the striatum and neurotransmitter
    signaling involved in interval timing. (A) Schematic representation of the relationship
    among oscillatory cortical inputs, medium spiny neurons, cholinergic interneurons,
    glutamatergic afferents, and dopaminergic axons projecting from the substantia
    nigra pars compacta (SNpc) to the striatum as specified by the Striatal Beat Frequency
    model of interval timing. The direct output pathway to the globus pallidus – external
    (GPe) and internal (GPi) segments, and substantia nigra reticulata (SNr) as well
    as the indirect pathway to the GPe are indicated. Relevant neurotransmitters = acetylcholine
    (ACh), dopamine (DA), γ-aminobutyric acid (GABA), glutamate (GLU). (B) Detail
    of dopaminergic, glutamatergic, and cholinergic input to a striatonigral medium
    spiny neuron as well as the principal signal transduction pathways modulating
    the contribution of striatal spiny neurons to interval timing. Abbreviations:
    AC, adenyl cyclase; ACh, acetylcholine; AMPAR, AMPA receptor; CB1, cannabinoid
    receptor type 1; CRE, cyclic-AMP-response element; CREB, CRE binding protein;
    DA, dopamine; DAG, 1,2-diacylglycerol; DARPP-32, camp-regulated phosphoprotein
    of 32 kDa; D1R, dopamine D1 receptor; D2R, dopamine D2 receptor; EC, endocannabinoids;
    GABA, γ-aminobutyric acid; Glu, glutamate; GP, globus pallidus; IP3, inositol
    1,4,5 trisphosphate; M1R, muscrinic acetylcholine receptor 1; M2R, muscarinic
    acetylcholine receptor 2; mGluR, metabotropic glutamate receptor; NMDAR, N-methyl-d-aspartic
    acid receptor; NOS, nitric oxide synthase; PKA, protein kinase A; PKC, protein
    kinase C; SNpc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata;
    STN, subthalamic nucleus; TrKR, tyrosine kinase receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pgi
  - Snr1
  - GABA-B-R1
  - Rdl
  - Gabat
  - achi
  - emc
  - da
  - nAChRalpha2
  - Galphai
  - Nmdar2
  - Nmdar1
  - mGluR
  - Dop2R
  - Dop1R2
  - Galphaq
  - CG17760
  - CG30054
  - ac
  - na
  - ca
  - Nacalpha
  - Cam
  - CaMKII
  - norpA
  - sl
  - Plc21C
  - cav
  - Nos
  - nos
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - ec
  - ras
  - Ras64B
  - Ras85D
  - GC
  - Raf
  - Pkg21D
  - Dsor1
  - Mtk
  - for
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Erk7
  - rl
  - CrebB
  - CrebA
  - mirr
  - GYPE
  - GPI
  - GNPDA1
  - FGFR3
  - CNR1
  - GRM2
  - DRD1
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - GRM1
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - DRD2
  - CHRM1
  - GNAQ
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - NACA
  - CALM1
  - CALM2
  - CALM3
  - KRIT1
  - CAMKMT
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - CACNA1D
  - CA5A
  - CAV2
  - CAV1
  - CAV3
  - BDNF
  - BDNF-AS
  - NOS1
  - NOS2
  - NOS3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRKG1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - EPHB2
  - MAPK1
  - MAPK3
  - PPP1R1B
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - GABA
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
